Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-27

Clinical Trial Update: Freeze-Dried MVA-BN® Lot Consistency Smallpox Trial [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the lot consistency of Freeze-Dried MVA-BN for smallpox has been completed, with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MVA-BN (Modified vaccinia Ankara Bavarian Nordic)

Snippet

Sponsor: Bavarian Nordic | Conditions: Smallpox | Phase 3 | Status: COMPLETED | Results posted: 2021-05-27